Product
Immune checkpoint inhibitors
1 clinical trial
2 indications
Indication
CancerIndication
Metastatic CancerClinical trial
Prediction of Immune-related Adverse Events Induced by Anti-CTLA4 and Anti-PD1/PDL1 Drugs by Means of a Battery of Autoantibodies. A Multicenter Prospective Observational Cohort StudyStatus: Recruiting, Estimated PCD: 2023-10-31